Through a venture philanthropy called Fast Forward, LLC the National Multiple Sclerosis Society plans to deploy 1.5 to 2 million dollars in the next 18 months as seed funding to biotech companies on the path towards cures for Multiple Sclerosis. Our guest, Timothy Coetzee executive director of Fast Forward, LLC joins host Dr. Bruce Bloom to talk about genomics, novel immune system therapies and other hopeful possibilities leading towards cures for multiple sclerosis. Interesting also is the process by which the biotech companies are evaluated and followed after an investment is made.